Financial Architects (New Jersey)’s Alaunos Therapeutics TCRT Stock Holding History

Financial Architects (New Jersey)’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2	Closed	-$1K	–	1453
2019 Q1	$1K	Hold	2	–	–	﹤0.01%	1389
2018 Q4	$1K	Sell	2 -1	-33%	-$395	﹤0.01%	1295
2018 Q3	$1K	Hold	3	–	–	﹤0.01%	1388
2018 Q2	$1K	Sell	3 -4	-57%	-$2.54K	﹤0.01%	1289
2018 Q1	$4K	Hold	7	–	–	﹤0.01%	1269
2017 Q4	$5K	Hold	7	–	–	﹤0.01%	1300
2017 Q3	$7K	Sell	7 -2	-22%	-$1.78K	﹤0.01%	1220
2017 Q2	$8K	Sell	9 -1	-10%	-$980	﹤0.01%	1193
2017 Q1	$9K	Buy	10 +3	+43%	+$2.79K	﹤0.01%	1166
2016 Q4	$6K	Hold	7	–	–	﹤0.01%	1130
2016 Q3	$6K	Sell	7 -1	-13%	-$804	﹤0.01%	1117
2016 Q2	$7K	Buy	+8	New	+$8.71K	﹤0.01%	1054
2015 Q3	–	Sell	-71	Closed	-$128K	–	829
2015 Q2	$128K	Buy	+71	New	+$110K	0.05%	258

Other funds holding TCRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Financial Architects (New Jersey)'s TCRT Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Alaunos Therapeutics (TCRT) in Q2 2019, closing a stake of 2 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in TCRT in Q2 2015 and held it in 13 quarters. The position peaked at $128K in Q2 2015. 140 funds tracked by Wall St. Rank hold TCRT as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Alaunos Therapeutics position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 2 Alaunos Therapeutics shares in Q2 2019, an estimated $1K.
Financial Architects (New Jersey) first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 13 quarters.
Financial Architects (New Jersey)'s Alaunos Therapeutics position peaked at $128K in Q2 2015.
140 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.